In our previous study (14), we found that LINC01134 confers oxaliplatin resistance by facilitating p62 Transcription in HCC, however, the effect of LINC01134 on oxaliplatin resistance failed to be completely abolished when p62 was knocked out, suggesting that there must be some other mechanisms mediating the effect of LINC01134 on oxaliplatin resistance, which needs further investigation. Here, LINC01134 is linked to hepatocellular carcinoma.